Skip to main content

RT @AurelieRheumo: Peresolimab PD-1 agonist in RA Phase 2 RCT Primary endpoint met w/ > improvement DAS28CRP Wk12

Nov 14, 2022 10:06 am
Social Author Name
Aurelie Najm
Tweet Content
Peresolimab PD-1 agonist in RA Phase 2 RCT Primary endpoint met w/ > improvement DAS28CRP Wk12 Also greater improvement of CDAI in both treated grps TEAEs PBO 37% PER 300mg 40% PER 700mg 35%, 1 serious AE in PER 700mghttps://t.co/QtclWIWAw9Abs#L03 #ACR22 @Rheumnow https://t.co/bLHP4JuNjt
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×